share_log

Stifel Initiates Coverage On Kura Oncology With Buy Rating, Announces Price Target of $25

Stifel Initiates Coverage On Kura Oncology With Buy Rating, Announces Price Target of $25

Stifel 以購買評級啟動庫拉腫瘤醫學的覆蓋範圍,宣布目標價格為 25 美元
Benzinga Real-time News ·  2023/01/31 04:37

Stifel analyst Bradley Canino initiates coverage on Kura Oncology (NASDAQ:KURA) with a Buy rating and announces Price Target of $25.

Stifel分析師布拉德利·卡尼諾對庫拉腫瘤學(納斯達克:庫拉)的報道給予買入評級,並宣佈目標價為25美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論